Skip to content

PET Respiratory Gating to Detect Hepatic Metastasis in Patients With Colon Cancer

Effects of Respiratory Gating on FDG/PET Detection of Hepatic Metastasis in Patients With Colon Cancer

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT01401309
Enrollment
81
Registered
2011-07-25
Start date
2011-01-31
Completion date
2013-03-31
Last updated
2014-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Colon Cancer

Brief summary

This study is to examine if there is improved sensitivity in detecting hepatic lesions using respiratory gating and if there is an improvement in confidence defining lesions as benign or malignant.

Interventions

None listed

Sponsors

Southwestern Regional Medical Center
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Patients with colon cancer * 18 years or older * Signed Informed Consent Form * Blood Glucose of 200 or less prior to scan

Exclusion criteria

* Patients with known hepatic metastasis

Design outcomes

Primary

MeasureTime frameDescription
DetectingJan 2011 - Nov 2011To exam if there is an improved sensitivity in detecting hepatic lesions using respiratory gating and if there is improvement in confidence defining lesions as benign or malignant

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026